[Ifenprodil (Vadilex). Its value in cochlear protective treatments in otospongiosis].
D003051:Cochlea / Q000098:blood supply / Q000187:drug effects*; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D010040:Otosclerosis / Q000601:surgery*; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010880:Piperidines; D011942:Receptors, Adrenergic, alpha; D014665:Vasodilator Agents; C010739:ifenprodil
L'ifenprodil (Vadilex). Son intérêt dans les traitements de soutien cochléaire dans l'otospongiose.